Biocept Reports 2015 Fourth Quarter and Full Year Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
Biocept (BIOC) Reports Q4 Loss of $0.24
March 9, 2016 5:05 PM ESTBiocept (NASDAQ: BIOC) reported Q4 EPS of ($0.24), versus ($0.87) reported last year. Revenue for the quarter came in at $218 million, versus $76 million reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
... More